BioCentury
ARTICLE | Company News

Depomed submits Proquin XR NDA

July 20, 2004 7:00 AM UTC

DEPO submitted an NDA to FDA for Proquin XR ( Ciprofloxacin GR) to treat uncomplicated urinary tract infections (UTIs). Proquin XR is a once-daily, extended-release formulation of ciprofloxacin that u...